Insulin Ultralente Mc

Insulin Ultralente MC: what is this drug and how does it work

Insulin Ultralente MC is a long-acting insulin used to control blood glucose levels in patients with diabetes. The drug is manufactured by Novo Nordisk A/S from Denmark and Torrent Pharmaceuticals from India.

Insulin Ultralente MC belongs to the group of long- and extra-long-acting insulins. Long-acting insulin means it works for several hours after administration, allowing patients to manage their blood glucose levels throughout the day. Ultra-long-acting means that insulin continues to work even longer, which can be helpful for patients who have trouble controlling their glucose levels at night or over long periods of time.

Insulin Ultralente MC is supplied in the form of an injection suspension with a concentration of 40 U/ml. It can be used as monotherapy or in combination with other drugs to control blood glucose levels.

One of the advantages of Insulin Ultralente MC is that it is less likely to cause hypoglycemia (low blood glucose) compared to other long-acting insulins. This is due to the fact that insulin Ultralente MC has a smoother action profile and is less likely to cause spikes in blood glucose levels.

However, like all insulins, Insulin Ultralente MC may cause side effects such as skin rash, itching, swelling and pain at the injection site. The development of hypoglycemia is also possible, especially if the dosage is not consistent with the patient’s diet and physical activity.

Overall, Insulin Ultralente MC is an effective drug for controlling blood glucose levels in patients with diabetes. However, before using it, you should consult your doctor and strictly follow the instructions for use to minimize the risk of side effects.